234 related articles for article (PubMed ID: 33507331)
1. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.
Krug D; Baumann R; Combs SE; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Strnad V; Budach W;
Strahlenther Onkol; 2021 Apr; 197(4):269-280. PubMed ID: 33507331
[TBL] [Abstract][Full Text] [Related]
2. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
3. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
[TBL] [Abstract][Full Text] [Related]
4. [Extreme hypofractionation: New indications for breast cancer radiotherapy].
Bockel S; Louvel G; Brion T; Ung M; Berthelot K; Villaret F; Auzac G; Milewski C; Rivera S
Cancer Radiother; 2021 Oct; 25(6-7):679-683. PubMed ID: 34452822
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
Chatterjee S; Chakraborty S;
Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
[TBL] [Abstract][Full Text] [Related]
6. Update on Accelerated Whole Breast Irradiation.
Shah C; Fleming-Hall E; Asha W
Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
[TBL] [Abstract][Full Text] [Related]
7. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds.
Yadav BS; Dey T
Clin Breast Cancer; 2024 Jul; 24(5):399-410. PubMed ID: 38614852
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials.
Tabrizi S; Trippa L; Cagney D; Aizer AA; Tanguturi S; Ventz S; Fell G; Bellon JR; Mamon H; Nguyen PL; D'Amico AV; Haas-Kogan D; Alexander BM; Rahman R
JAMA Netw Open; 2021 Mar; 4(3):e213304. PubMed ID: 33779742
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiation therapy for invasive breast cancer: From moderate to extreme protocols.
Rivera S; Hannoun-Lévi JM
Cancer Radiother; 2019 Dec; 23(8):874-882. PubMed ID: 31611051
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
[TBL] [Abstract][Full Text] [Related]
14. Cost Minimization Analysis of Hypofractionated Radiotherapy.
Yaremko HL; Locke GE; Chow R; Lock M; Dinniwell R; Yaremko BP
Curr Oncol; 2021 Jan; 28(1):716-725. PubMed ID: 33573158
[TBL] [Abstract][Full Text] [Related]
15. Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.
Arsenault J; Parpia S; Goldberg M; Rakovitch E; Reiter H; Doherty M; Lukka H; Sussman J; Wright J; Julian J; Whelan T
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):943-948. PubMed ID: 32334033
[TBL] [Abstract][Full Text] [Related]
16. From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy.
Yarnold JR; Brunt AM; Chatterjee S; Somaiah N; Kirby AM
Clin Oncol (R Coll Radiol); 2022 May; 34(5):332-339. PubMed ID: 35318945
[TBL] [Abstract][Full Text] [Related]
17. [Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results].
Chaffai I; Cao K; Kissel M; El Ayachy R; Aboudaram A; Fourquet A; Kirova Y
Cancer Radiother; 2022 Jun; 26(4):542-546. PubMed ID: 34454837
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated radiation treatment in the management of breast cancer.
Gupta A; Ohri N; Haffty BG
Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionation: The standard for external beam breast irradiation.
Brunt AM; Haviland JS
Breast; 2023 Jun; 69():410-416. PubMed ID: 37120889
[TBL] [Abstract][Full Text] [Related]
20. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
Brunt AM; Wheatley D; Yarnold J; Somaiah N; Kelly S; Harnett A; Coles C; Goodman A; Bahl A; Churn M; Zotova R; Sydenham M; Griffin CL; Morden JP; Bliss JM;
Radiother Oncol; 2016 Jul; 120(1):114-8. PubMed ID: 27046390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
